A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of PC945
Clinical trial NCT02715570 · COMPLETED
Trial details
- NCT number
- NCT02715570
- Sponsor
- Pulmocide Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-23
- Primary completion
- 2018-04-27
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.